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Abstract
Background & Aim
The ability of Staphylococcus aureus to successfully colonize (a)biotic surfaces may be
explained by biofilm formation and the actions of virulence factors. The aim of the present
study was to establish the presence of 52 proteins, including virulence factors such as
alpha-toxin, during biofilm formation of five different (methicillin resistant) S. aureus strains
on Leiden human epidermal models (LEMs) and polystyrene surfaces (PS) using a compet-
itive Luminex-based assay.
Results
All five S. aureus strains formed biofilms on PS, whereas only three out of five strains formed
biofilms on LEMs. Out of the 52 tested proteins, six functionally diverse proteins (ClfB, gluco-
saminidase, IsdA, IsaA, SACOL0688 and nuclease) were detected in biofilms of all strains on
both PS and LEMs. At the same time, four toxins (alpha-toxin, gamma-hemolysin B and leu-
kocidins D and E), two immunemodulators (formyl peptide receptor-like inhibitory protein and
Staphylococcal superantigen-like protein 1), and two other proteins (lipase and LytM) were
detectable in biofilms by all five S. aureus strains on LEMs, but not on PS. In contrast, fibro-
nectin-binding protein B (FnbpB) was detectable in biofilms by all S. aureus biofilms on PS,
but not on LEMs. These data were largely confirmed by the results from proteomic and tran-
scriptomic analyses and in case of alpha-toxin additionally by GFP-reporter technology.
Conclusion
Functionally diverse virulence factors of (methicillin-resistant) S. aureus are present during
biofilm formation on LEMs and PS. These results could aid in identifying novel targets for
future treatment strategies against biofilm-associated infections.
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Introduction
Staphylococcus aureus (S. aureus) is the causative agent of a variety of infections with generally
significant morbidity and mortality. The incidence of both hospital and community acquired
infections caused by methicillin-resistant S. aureus (MRSA) has increased significantly in the last
decades [1–3]. Unfortunately, the treatment of such infections is becoming increasingly complex
as current antibiotics may be less effective due to resistance development and biofilm formation
[4]. As the number of newly approved antimicrobial agents continues to decrease [5,6], alterna-
tive strategies for prevention and/or treatment of bacterial colonization and infection, such as a
vaccines [7] and antimicrobial peptides [8], are urgently needed. To date no clinically successful
vaccine against S. aureus has been developed, despite the promising results of vaccines targeting
diverse virulence factors of this pathogen in animal models [9,10]. Currently, the awareness that
multiple virulence factors of S. aureus should be targeted for any vaccine or other strategy to be
successful is increasing [9]. Moreover, some relation between the expression of antibodies against
S. aureus virulence factors and protection from infection has been made [11].
The capacity of S. aureus to cause infections is attributed to its vast array of virulence factors
which include adhesive surface proteins, secreted immune modulators, enzymes and toxins
[7]. Moreover, many infections such as those of (wounded) skin, mucosae and artificial sur-
faces [12] are believed to involve biofilm formation by S. aureus. Biofilms are defined as com-
plex communities of bacteria encased in an extracellular polymeric matrix and biofilm
formation is believed to contribute to bacterial virulence, reduced susceptibility to antibiotics
[13–15] and reduced clearance by the immune system. Despite the plethora of studies examin-
ing the involvement of biofilm formation [16] and/or single virulence factors [17,18] in e.g.
skin infections, so far only a few studies has focussed on the involvement of multiple virulence
factors in association with biofilm formation by S. aureus during infection [19,20].
Biofilm formation by S. aureus on polystyrene (PS) has been extensively characterized
before [21,22]. However, biofilm formation on human biotic surfaces is much less character-
ized and the associated pathogen-host interactions are unclear. Earlier we reported that Leiden
epidermal models (LEMs) mimic the human skin in many ways, including epidermal morphol-
ogy and barrier properties [23]. In addition, full thickness human skin equivalents have been
used to study skin colonization by (methicillin resistant) S. aureus [24,25].
The aim of the current study was to establish the presence of 52 proteins, including viru-
lence factors such as alpha-toxin, during biofilm formation by five different (methicillin-resis-
tant) S. aureus strains on LEMs and PS. Using the novel competitive Luminex-based assay
(CLA; [26] we detected six proteins (ClfB, glucosaminidase, IsdA, IsaA, SACOL0688 and
nuclease) in biofilms of all biofilm-forming strains on the two surfaces. At the same time, sur-
face- and strain-dependent differences were found for the presence of a wide range of other
proteins, such as immune modulators and toxins like alpha-toxin.
Materials and Methods
Ethics statement
Human serum was obtained from healthy volunteers who gave written consent for use of
serum solely for research purposes within the department of Medical Microbiology and Infec-
tious Diseases at the Erasmus MC Rotterdam. Serum was coded, pooled and has been used for
this and earlier studies [27,28]. The original list with documented volunteer names was only
accessible to qualified physicians within the department, amongst the current authors only
including PMdR. This sampling procedure was approved by the Medical Ethics Committee of
the Erasmus Medical Center Rotterdam (MEC-2007-106, addendum 2) [28]. All primary
Detection of S. aureus Virulence Factors during Biofilm Growth
PLOS ONE | DOI:10.1371/journal.pone.0145722 January 7, 2016 2 / 19
human skin cells from healthy donors used by the Department of Dermatology are isolated
from surplus tissue collected according to article 467 of the Dutch Law on Medical Treatment
Agreement and the Code for proper Use of Human Tissue of the Dutch Federation of Biomedi-
cal Scientific Societies [29]. According to article 467, coded anonymous surplus tissue can be
used if no objection is made by the patient. All patients were informed of the possibility that
surplus tissue could be used for scientific research and all patients were offered the opportunity
to give written refusal to this. Only tissue from patients who did not opt out was used. None of
the authors were involved in the tissue sampling and only birth date, gender and skin type of
the subjects were documented. These data were only accessible to EMH and PHN. Because this
procedure, as published previously [8,24–25], is in accordance with national law and additional
approval of an ethics committee regarding scientific use of surplus tissue is not required, we
did not seek specific approval by our ethics committee. The Declaration of Helsinki principles
were followed when working with human tissue.
Staphylococcus aureus strains
The following S. aureus strains were used in this study: methicillin-resistant strains LUH14616
(sequence type 247), a kind gift of dr. S. Croes [30]; LUH15051 (ST 239) obtained from dr. M.
E.O.C. Heck, (Laboratory of Infectious Diseases and Screening, RIVM, Bilthoven, The Nether-
lands); USA300 strain Sac042w (ST 8) described earlier [31]; a strain derived from an impetigo
patient LUH15091 (ST121) within the Erasmus Medical Center and NCTC 8325–4 (ST 8). All
strains were typed using multi locus sequence typing (MLST) [27,32]. Before usage the strains
were grown on sheep blood agar plates (Biomerieux).
Biofilm formation on polystyrene plates
A routine biofilm model was used as described before [21,22]. In short, overnight plate cultures
of S. aureus were re-suspended in Iscove’s Modified Dulbecco’s Medium (IMDM, Life technol-
ogies, Carlsbad, CA, USA) without phenol red until an optical density (OD, 660nm) of 2 was
reached. IMDMmedium was chosen because of its significant impact on detectable levels of
bacterial proteins, e.g. IsdA, ClfB and Efb, expressed by S. aureus biofilms on PS [26]. One μl of
this bacterial suspension was added to 199 μl of TSB supplemented with 0.5% (wt/v) glucose
and 3% (wt/v) NaCl or IMDM without any supplement in sterile 96-wells PS plates (Greiner
Bio-one). Plates were then incubated at 37°C with gentle shaking at 200 rpm for various inter-
vals. Biofilm mass was measured by staining with 1% crystal violet. OD was measured at
490 nm.
Leiden epidermal models
The epidermis and dermis of pieces of fresh plastic surgery surplus skin were enzymatically
and mechanically separated, and each layer was subsequently digested to obtain single-cell sus-
pensions [33]. The keratinocytes were cultured in keratinocyte medium, i.e. 3 parts DMEM
(Gibco/Invitrogen) and 1 part Ham's F12 medium supplemented with 5% (v/v) fetal bovine
serum (FBS; HyClone/Greiner), 0.5 μM hydrocortisone, 1 μM isoproterenol, 0.1 μM insulin (all
from Sigma–Aldrich, Zwijndrecht, The Netherlands), 100 U/ml penicillin and 100 μg/ml strep-
tomycin (both from Invitrogen). Leiden epidermal models (LEMs; Fig 1A) were made with
these primary human keratinocytes as described before [34]. Briefly, one day before generation
of the models, medium of the keratinocyte cultures was switched to Dermalife (Lifeline Cell
Technology) supplemented with penicillin (10,000 U/ml) and streptomycin (10 mg/ml). The
next day 2×105 keratinocytes were seeded onto a filter insert (0.4 μMCostar inserts; Corning)
in 12-well plates in this Dermalife medium. Three days thereafter the apical medium was
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removed, leaving the keratinocytes air-exposed. The medium under the filter insert was
switched to CnT-02-3D medium (CellnTech) mixed with keratinocyte medium supplemented
with 2.4×10−2 μM bovine serum albumin and lipids/antibiotics as described above. One day
before bacterial inoculation of the LEMs, the medium was switched to this medium without
antibiotics. All experiments were performed on 10-day air-exposed cultures.
Fig 1. Biofilm formation by S. aureus LUH14616 on LEMs and PS surfaces. (A) Schematic representation of LEM. (B) Bacterial counts were performed
on LEM exposed to LUH14616 for various intervals. Adherent bacteria are represented by open symbols and non-adherent/loosely adherent bacteria by
closed symbols. Results are displayed as the mean and SD of four experiments. (C) Haematoxilin and eosine staining of LEMs at various intervals after
inoculation with LUH14616. Arrows indicate microcolonies, scale bars = 50 μm. (D) Cryo scanning electron microscopy of LEMs colonized with LUH14616
for various intervals. Photographs are representative for three different keratinocyte donors. (E) Biofilm formation by LUH14616 on PS in IMDMmedium.
Results are the mean and SEM of three experiments. (F) Cryo scanning electron microscopy of S. aureus LUH14616 biofilms formed on PS at 24 and 48 hrs
after adherence to wells. Scale bars = 1 μm.
doi:10.1371/journal.pone.0145722.g001
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Colonization of Leiden epidermal model
LEMs were exposed for 1 h at 37°C in 7.3% CO2 to 300 μl of a log-phase bacterial suspension
containing 3.3x105 CFU/ml. Next, the non-adherent bacteria were removed by aspiration and
at different intervals thereafter, the viable detachable bacteria were collected in 1 ml of PBS,
and serially diluted, and 50 μl of these samples were plated onto diagnostic sensitivity test
(DST) agar plates (Oxoid) to determine the number of CFU. To assess the number of adherent
bacteria, a model was cut in two equally sized pieces. One piece was used for histology and the
other was homogenized in PBS using a glass Potter-Elvehjem tissue homogenizer, and the
homogenates were subsequently serially diluted and plated as described above. The lower limits
of detection for detachable and adherent bacteria were 20 and 40 CFU/LEM, respectively.
Histology
One biopsy of each model was fixed in 4% (v/v) formaldehyde, dehydrated, and embedded in
paraffin. Next, paraffin blocks were cut into 5-μm sections, deparaffinized, rehydrated, and
then stained with hematoxylin and eosin (H&E) staining.
Cryo scanning electron microscopy
For the morphological study of (methicillin resistant) S. aureus biofilms on LEM or PS by
cryo-scanning electron microscopy (SEM), specimens were quickly frozen in liquid nitrogen
slush and transferred directly to the cryo-transfer attachment (Gatan Alto2500). Samples were
sublimated at -90 in high vacuum for 5 min and subsequently sputter-coated with a layer of
20 nm gold/paladium and examined in a JEOL JSM6700F scanning electron microscope.
Multiplex bead assay for assessment of the presence of proteins during
S. aureus biofilm formation
Amultiplex competitive Luminex assay [26] (CLA) with minor modifications was used to indi-
rectly detect the presence of 52 IgG-accessible proteins in bacterial cultures (all bacterial pro-
teins are described in S1 File). In brief, log-phase cultures of S. aureus were diluted 1:200 and
incubated in PS wells for 1, 8, 24 and 48 hrs. After washing with ice-cold PBS supplemented
with 0.5% (wt/v) sodium azide (Sigma-Aldrich), adherent bacteria residing in biofilms on PS
or LEMs were incubated at 8°C and continuous shaking (500 rpm) with 200 μl of a 1:200 dilu-
tion of polyclonal human IgG (PHG), isolated using the HiTrap™ Protein G HP column
according to the manufacturer’s guidelines (GE Healthcare Bio-sciences, Piscataway, New Jer-
sey, USA), from pooled serum of 40 healthy volunteers (19 non-nasal carriers, 6 intermittent
and 15 persistent nasal carriers of S. aureus as determined earlier [35]. After 35 min incubation
the PHG samples were recovered from biofilms. The remaining non-bound IgG antibody levels
in these samples, specifically directed against 52 proteins of S. aureus, were measured using a
multiplex bead-based flow cytometry technique (xMAP1, Luminex corporation) wherein
recombinant proteins were covalently coupled to the beads as described previously [27,28,36].
As negative controls PHG samples incubated with empty PS wells or sterile LEMs were
included in all experiments.
Next, the percentage decrease in the levels of specific IgG antibodies for each protein was
calculated in relation to the negative control. The percentage decrease can be considered a
semi-quantitative measure of the protein-specific antibody absorption from PHG by the bio-
film, thus indirectly reflecting the presence of the particular S. aureus protein by the biofilm
[26]. The average percentage decrease plus two times the standard deviation, obtained at 8, 24
and 48 hours biofilm growth, for the three non-S. aureus control proteins and all S. aureus
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proteins of which genes were not present in LUH14616 were chosen as cut-off value (35% at 8
and 24 hrs biofilm growth and 40% at 48 hrs, respectively).
In case of bacteria adherent to LEMs, the same protocol was followed with the single modifi-
cation that PHG samples were directly incubated on top of the LEM. To determine the pres-
ence of S. aureus proteins in culture supernatants, growth medium that covered biofilms
grown on PS was analyzed using the same protocol, with the modification that medium was
removed at designated time points and incubated with PHG samples in sterile wells.
Reverse transcriptase PCR
Early biofilms (8 and 16 hrs) were grown in 96-well plates (Cellstar culture plates, Greiner
Bio-One) in 200 μl of IMDM (Gibco). Biofilms were resuspended, pooled and centrifuged at
4000 rpm for 10 min at 4°C. Pellets were resuspended in 200 μl of RNA protect™ Bacterial
reagents (Qiagen), stabilized for 5 min and then centrifuged for 10 min at 4°C. The pellet was dis-
solved in 1 ml of RNA-pro solution (Fast RNA Pro Blue kit, MP Biomedicals) and stored at
-20°C until use. RNA was isolated using the Fast RNA Pro Blue kit according to the manufactur-
er’s protocol. Each 10 μg of isolated RNA was treated twice with 2 U TURBO DNase (Ambion,
Life Technologies). The reaction was stopped by adding 0.2 volumes of DNase inactivation
reagent (Ambion) and incubation for 2 min at ambient temperature. RNA containing superna-
tants were collected by centrifugation (1.5 min at 9000 g at ambient temperature) and each 2 μg
DNase-treated RNA was treated with 2 U DNase I (Fermentas, Fisher Scientific). One μg of pre-
pared RNA was transcribed into cDNA using 200 U RevertAid HMinus Reverse transcriptase
(Fermentas), 4 μl of 5x reaction buffer (Fermentas), 20 U of RiboLock RNase inhibitor (Fermen-
tas) and 2 μl of 10 mM dNTPmix (Fermentas) in a final volume of 20 μl of DEPC-treated water.
This was incubated for 60 min at 42°C and then terminated by heating at 70°C for 5 min. For
each RNA sample a negative control without reverse transcriptase was processed similarly. The
presence of cDNA in all samples was examined using PCR as described previously [27].
Proteomics
A total of 48 biofilms of strain LUH14616 were grown for 8 hours in PS wells as described
above, resuspended in 200 μl of PBS per well, pooled and spun down at 4,000 rpm for 5 min.
The resulting pellet was resuspended in 50 μl of PBS, mixed with 50 μl of Laemni buffer and
heated for 5 min at 95°C. Fifty μl of this suspension containing denatured proteins were run
on a 15% SDS gel (Biorad) and gel lanes were cut into ~1 mm slices. Lanes were subjected to
in-gel reduction with dithiothreitol, alkylation with chloroacetamide and digestion with trypsin
(Promega, Leiden, The Netherlands). Nanoflow LC-MS/MS was performed on an 1100 series
capillary LC system (Agilent Technologies) coupled to an LTQ Orbitrap XL mass spectrometer
(Thermo), operating in positive mode and equipped with a nanospray source. Mass spectra
were acquired in continuum mode; fragmentation of the peptides was performed in data-
dependent mode by CID. Peak lists were automatically created from raw data files using the
Proteome Discoverer (version 1.3; Thermo). The Mascot search algorithm (version 2.2,
MatrixScience) was used for searching against the Uniprot database (release 2013_06.fasta, tax-
onomy: S. aureus, strains USA300, Newman, NCTC 8325–4 and COL). The peptide tolerance
was set to 10 ppm and the fragment ion tolerance was set to 0.8 Da. A maximum number of
2 missed cleavages by trypsin were allowed and carbamido-methylated cysteine and oxidized
methionine were set as fixed and variable modifications, respectively. The Mascot score cut-off
value for a positive protein hit was set to 65. Individual peptide MS/MS spectra with Mascot
scores below 25 were checked manually and either interpreted as valid identifications or
discarded.
Detection of S. aureus Virulence Factors during Biofilm Growth
PLOS ONE | DOI:10.1371/journal.pone.0145722 January 7, 2016 6 / 19
Construction of the hla promotor upstream of GFPuvr
S. aureus strains LUH14616 and Sac042w containing a vector with an hla promotor upstream
of GFPuvr were prepared as described earlier [37] with some modifications. First, the promotor
of hla was amplified using primers hlapr1 (cggaattcgatatttctatgtaatggca) and hlapr2 (gctcta-
gacttctatttttttgaacgat) and as a template DNA from S. aureus strain Newman. Next, the amplifi-
cation product was ligated into the EcoRI XbaII site of pALC1484 (a kind gift from dr A.L.
Cheung, Dartmouth College, New Hampshire, US) and cloned into E. coliDH10beta. From
positive colonies on LB agar supplemented with 50 μg of ampicillin/ml, recombinant plasmids
were isolated, checked by PCR and sequencing, and then electroporated into S. aureus
RN4220. Finally, from positive colonies on BHI agar supplemented with 10 μg of chloram-
phenicol/ml, plasmids were isolated and electroporated into S. aureus LUH14616 and
Sac042w. As positive and negative control we electroporated respectively pWVW 163, a plas-
mid containing a phage promotor yielding a strong, constant expression of GFP, and
pALC1484, an empty vector [38], into the same S. aureus strains as described above.
Data analysis
All data were analysed using Microsoft Excel version 2010 and graphics were made using
Graphpad Prism version 5 (Graphpad Inc. La Jolla, CA, USA).
Results
Biofilm formation by MRSA strain LUH14616 on LEMs and PS
Firstly, the ability of the clinical isolate MRSA LUH14616 to form biofilms on both the human skin
model (Leiden Epidermal Model: LEM, schematically represented in Fig 1A), and polystyrene (PS)
was examined. This MRSA strain was able to adhere to and stably colonize both surfaces, as
reflected by an increase in bacterial counts on LEM (Fig 1B) and an increase in crystal violet stain-
ing on PS (Fig 1E) within the first 24 hrs after inoculation. Interestingly, haematoxylin-eosin stain-
ing of the colonized LEMs showed that the bacteria adhered to the stratum corneum and formed
small colonies after 16 hrs, but did not invade the epidermis (Fig 1C). To further examine biofilm
formation byMRSA strain LUH14616 on these surfaces, bacterial colonization on LEM (Fig 1D)
and PS (Fig 1F) was visualized with scanning electron microscopy. Results revealed a tightly adher-
ent layer of bacteria on both LEMs and PS after 24–48 hrs, indicating the development of a mature
biofilm on both surfaces. Biofilm-associated bacteria on LEM appeared to be completely encased in
an extracellular matrix (Fig 1D), while bacteria on PS appeared to be incompletely encased (Fig 1F).
Detection of toxins, immune modulators and other proteins of MRSA
strain LUH14616 during biofilm formation on PS
We used a competitive Luminex-based assay (CLA) to establish the presence of 52 bacterial
proteins during biofilm formation by MRSA strain LUH14616 on polystyrene (PS).
In line with previous results [26], biofilm mass-dependent absorption of specific IgG for
several S aureus proteins, such as IsdA (Fig 2A), FnbpB (Fig 2C) and glucosaminidase by bio-
films was detected, while no such reduction was seen for the levels of IgG antibodies directed
against control proteins, e.g. the protein derived from human metapneumovirus (hMPV) (Fig
2B). Based on the percentage decrease in the levels of IgG directed against the three non-S.
aureus control proteins and against the 28 S. aureus proteins of which genes were not found in
LUH14616 using PCR, cut-off values of at least 35% decrease in specific IgG at 24 hrs biofilm
growth and 40% at 48 hrs were calculated. CLA measurements for five proteins [ESX-1-associ-
ated factors EsxA and EsxB, iron surface determinants H (IsdH), Staphylococcal enterotoxin J
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(SEJ) and foldase-protein PrsA] were excluded from further analysis due to low MFI’s with
standard deviations larger than 25% between repeated CLA measurements.
Using the above mentioned cut-off values, we detected 8 proteins in 24 hrs and 48 hrs-old S.
aureus biofilms: the surface proteins fibronectin-binding protein B (FnbpB), CflB, glucosami-
nidase, iron-responsive surface determinant A (IsdA), immunodominant antigen A (IsaA),
SACOL0688, nuclease, and the immune modulator Efb (Table 1). In addition, a significant
decrease in the levels of IgG specifically directed against chemotaxis inhibitory protein of S.
aureus (CHIPS) with 48 hrs-old biofilms, but not 24 hrs-old biofilms, was observed. No signifi-
cant decrease in the levels of specific IgG for 15 other proteins, despite the presence of corre-
sponding genes in LUH14616 such as for alpha toxin, was observed (Fig 2D). Additional
experiments showed that the secreted proteins alpha-toxin, HlgB, FLIPr and SSL1 could nei-
ther be detected in the growth medium covering biofilms, excluding the possibility of false-neg-
ative signals for these secreted proteins (S1 Fig). CLA data were further validated by
confirming the presence of 7 out of the 8 detected proteins in early (8 hrs) biofilms using mass-
spectrometry, while mRNA was detected for 5 of these proteins in early biofilms.
Fig 2. Detection of S. aureus proteins during biofilm formation of LUH14616 on PS. Closed symbols indicate the mean fluorescence intensity (MFI, left
Y-axis), reflecting the level of remaining non-bound IgG directed against specific proteins after incubation of PHG with the biofilms, while open symbols
indicate biofilm mass (OD490 nm, right Y-axis). Both are plotted against the time of biofilm growth (hrs). Results are shown for (A) IsdA, (B) control protein of
humanmetapneumovirus (hMPV), (C) FnbpB and (D) alpha toxin. Dashed horizontal lines indicate the average MFI of sterile controls. Symbols and error
bars indicate mean and SD of four experiments.
doi:10.1371/journal.pone.0145722.g002
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Detection of toxins, immune modulators and other proteins of MRSA
strain LUH14616 during biofilm formation on LEMs
Next we screened for the presence of the same 52 proteins in biofilms of LUH14616 grown on
LEM. Similar to biofilms grown on PS we observed time dependent absorption of antibodies against
Table 1. Detection of mRNA and proteins during biofilm formation of LUH14616 on LEMs and PS.
Bioﬁlms on polystyrene Bioﬁlms on polystyrene Bioﬁlms on LEM
mRNA present3 Protein detectable4 Signiﬁcant reduction in
speciﬁc IgG5
Signiﬁcant
reduction in
speciﬁc IgG5
Protein1 Gene2 Functional class 8 hrs 8 hrs 8 hrs 24 hrs 48 hrs 24 hrs 48 hrs
CHIPS chp immmune modulator Yes Yes - - + - +
ClfB clfB surface protein Yes Yes + + + + +
Glucosaminidase Atl housekeeping No Yes + + + + +
IsaA isaA housekeeping Yes Yes + + + + +
IsdA isdA surface protein Yes Yes + + + + +
Nuc nuc housekeeping/ toxin No Yes + + + + +
SACOL0688 MntC housekeeping Yes Yes + + + + +
Efb efb immmune modulator No Yes + + + - -
FnBPB fnbB surface protein Yes No + + + - -
Alpha toxin hla toxin Yes No - - - + +
FlipR ﬂr immmune modulator Yes No - - - + +
HlgB hlgB toxin Yes No - - - + +
Lipase lip housekeeping/ toxin Yes No - - - + +
LukD lukD toxin Yes No - - - + +
LukE lukE toxin Yes No - - - + +
LytM lytM housekeeping Yes No - - - + +
SSL1 ssl1 immmune modulator Yes No - - - - +
FnBPA fnbA surface protein No Yes - - - - -
SCIN scn immmune modulator Yes No - - - - -
SdrD sdrD surface protein Yes Yes - - - - -
SEA sea toxin Yes No - - - - -
SSL3 ssl3 immmune modulator Yes No - - - - -
SSL5 ssl5 immmune modulator Yes No - - - - -
SSL10 ssl10 immmune modulator Yes No - - - - -
1Only proteins are shown for which corresponding genes were detected in LUH14616 and for which standard deviation between 4 CLA experiments did
not exceed 25%. From top to bottom protein groups are shown that were detected on both LEMs and PS, only on PS, only on LEMs or on neither surface,
respectively.
2Additional ORF IDs for all genes, based on sequences of S. aureus strain 8325–4 (SAOUHSC) or Newman (NWMN), are available online (http://www.
uniprot.org/).
3Presence of mRNA was established using RT-PCR in early 8 hrs bioﬁlms on PS.
4Presence of proteins was established using mass spectrometry in early 8 hrs bioﬁlms on PS
5Signiﬁcant reduction in the levels of IgG speciﬁc for each protein, indicative of the presence of the protein during bioﬁlm formation, was deﬁned as a
reduction in IgG (compared to sterile controls) of at least 35% at 8 and 24 hrs bioﬁlm growth and 40% at 48 hrs.
doi:10.1371/journal.pone.0145722.t001
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diverse antigens such as IsdA (Fig 3A) and glucosaminidase, whereas no such reduction was ob-
served for antibodies directed against the non-S. aureus control proteins (Fig 3B) and the proteins
of which the gene was not found in LUH14616. This prompted us to use the same cut-off values.
Thirteen proteins were detected in 24 and 48 hrs-old biofilms on LEMs (Table 1): the surface
proteins clumping factor B (CflB), glucosaminidase, IsdA, IsaA, glycyl-glysine endopeptidase
(LytM), and SACOL0688; the toxins alpha-toxin (Fig 3D), gamma-hemolysin B (HlgB), leukoci-
dins (Luk) D and E, lipase and nuclease; and the immune modulator formyl peptide receptor-
like inhibitory protein (FLIPr). In addition, CHIPS and staphylococcal superantigen-like protein
1 (SSL 1) were detected in 48 hrs biofilms, but not 24 hrs biofilms. In contrast to biofilms on PS,
no significant reduction was observed for antibodies against FnbpB at any time point (Fig 3C).
Detection of proteins during biofilm formation on LEMs and PS by
different S. aureus strains
To determine whether the results obtained for MRSA LUH14616 are representative for other
S. aureus strains, experiments with 24 hrs-old biofilms of an additional set of four, genetically
Fig 3. Detection of S. aureus proteins during biofilm formation of LUH14616 on LEMs. Closed symbols indicate the mean fluorescence intensity (MFI,
left Y-axis), reflecting the level of remaining non-bound IgG directed against specific proteins after incubation of PHG with the bacterial biofilms, while open
symbols indicate biofilm mass (OD490 nm, right Y-axis). Both are plotted against the time of biofilm growth (hrs). Results are shown for (A) IsdA, (B) control
protein of humanmetapneumovirus (hMPV), (C) FnbpB and(D) alpha toxin. Dashed horizontal lines indicate the average MFI of sterile controls. Symbols and
error bars indicate mean and SD of four experiments, respectively.
doi:10.1371/journal.pone.0145722.g003
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diverse S. aureus strains were performed: i.e. LUH15051, LUH15091, the USA300 strain
Sac042w, and NCTC 8325–4. Results revealed considerable variance in biofilm mass formed on
the PS plates and LEMs among the different strains (Fig 4A–4C). Interestingly, strains 8325–4
and LUH15091 formed a significant biofilm on PS, but not on LEMs. The latter two strains were
therefore excluded from further analyses. The same cut-off values were used as for LUH14616.
In agreement with the results for LUH14616, the proteins ClfB, IsdA, IsaA, SACOL0688
and glucosaminidase were detected in 24 hrs-old biofilms of LUH15051 and Sac042w on both
PS and LEMs (S1 Table). In addition, the toxins HIgB, LukD and E and the immune modulator
SSL1 were detected in biofilms of both strains only on LEMs, while FnBPB was detected only
on PS. In contrast to results obtained with LUH14616, we additionally detected the proteins
CHIPS, efb, lipase and lytM (in biofilms of both LUH15051 and Sac042w) and alpha-toxin and
FLipR (Sac042w only) on both surfaces. Finally, we detected SEA in biofilms of LUH15051 and
Sac042w on respectively LEMS and PS, while SdrD was detected for both strains on LEMS.
Alpha-toxin expression by MRSA strains LUH14616 and Sac042w
during biofilm formation on LEMs and PS
The differential detection of alpha-toxin, an important virulence factor during skin infections
caused by S. aureus, in biofilms of different strains on LEMs and PS was further investigated
Fig 4. Biofilm formation by 5 different S. aureus strains on LEMs and PS surfaces. (A) Biofilm formation
after 24 hrs on PS was measured by crystal violet staining. (B) Hematoxylin and eosine staining of LEMs
24 hrs after exposure to S. aureus 8325–4, LUH15091, LUH15051, LUH14616 or Sac042w, arrows
indicate S. aureus. Photographs are representative for three different experiments. Scale bars = 50 μm. (C)
The number of viable bacteria present on epidermal models after 24 hrs inoculation was determined
microbiologically (CFU/LEM). Results are boxplots showing the median and range. Results are means and
SEM of three to five experiments.
doi:10.1371/journal.pone.0145722.g004
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using GFP-reporter technology. Visualization of alpha-toxin produced by S. aureuswas performed
by using strains LUH14616 and Sac042w transformed with a vector containing the promoter for
hla, coupled to GFP. Using fluorescence microscopy, small microcolonies of these bacteria were
observed that did not express hla after 4 hrs of colonization of epidermal models (Fig 5A), whereas
at 24 hrs of colonization LUH14616 highly expressed hla, as indicated by the green fluorescent sig-
nal (Fig 5B). In contrast to results seen at the protein level, hla expression by LUH14616 was also
visualized after 24 hrs of colonization of polystyrene (S2 Fig), suggesting that the gene is tran-
scribed but not translated and/or that protein is rapidly degraded. Similar results were obtained
for Sac042w, although this was less pronounced than for LUH14616 (Fig 5B, S2 Fig).
Fig 5. Expression of hla by S. aureus LUH14616 and Sac042w during biofilm formation on LEMs. LUH14616 and Sac042w containing hla-GFP (hla),
empty vector (empty vec) or a construct yielding constant GFP expression (GFP), (A) at 4 hrs and (B) at 24 hrs after bacterial colonization of LEMs. LEMs
were incubated for 4 or 24 hrs with the different bacterial strains, subsequently fixed in 1% paraformaldehyde, and stained with DAPI. hla expressing bacteria
are presented in green, DAPI staining is presented in blue. Scale bars = 50 μm.
doi:10.1371/journal.pone.0145722.g005
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Discussion
In this study we established the presence of 52 proteins in biofilms of five genetically different
S. aureus strains on two different types of surfaces, i.e. Leiden epidermal modes (LEMs) and
polystyrene (PS). We detected six functionally diverse proteins in biofilms of three different
strains on both surfaces. Several of these proteins, including ClfB, glucosaminidase and
SA0688, have been previously associated with biofilm formation [39–42], although so far not
on a human biotic surface. In this context, surface- and strain-dependent differences in the
presence of a wide range of proteins, including alpha-toxin, were found. The detection of mul-
tiple toxins (HlgB, LukD/E and alpha toxin) in biofilms of multiple strains on LEMs, but not
PS, indicates surface specific protein expression. This implicates that currently used biofilm
models, such as those on PS, might not adequately reflect biofilm formation on a more complex
surface, such as the human skin. However, we should realize that the biofilms on LEMs and PS
were formed under different conditions, i.e. submerged in culture medium for biofilms on PS
and on an air-exposed, dry surface in case of biofilm formation on LEMs.
Biofilm formation by strain LUH14616 on LEMs and PS was confirmed using EM. Interest-
ingly, bacteria in a biofilm on LEM but not on PS were completely encased by an extracellular
matrix, indicating a phenotypic difference in bacterial biofilm formation on the two models.
However, in the current study we did not characterize the material encasing bacteria in more
detail, e.g. using immunoelectron microscopy [43].
The detection of S. aureus toxins, most notably alpha-toxin, in biofilms on LEMs is in agree-
ment with their well-established roles in the pathogenesis of skin infections [18,44]. The cyto-
lytic pore-forming alpha-toxin [45] lyses human cells including skin tissue, interferes with the
innate and adaptive immune responses in a murine skin infection model [46], and is essential
for biofilm development on mucosal surfaces [47]. Interestingly, in human skin, the filaggrin
protein may inhibit alpha-toxin’s cytotoxicity by its ability to regulate the secretion of sphingo-
myelinase [48]. In line with this,>90% of the atopic dermatitis (AD) patients, who often have
reduced filaggrin expression, are colonized by S. aureus [49], whereas about 25% of the normal
population is persistently colonized by this bacterium [50]. Moreover, S. aureus strains isolated
from AD patients displayed a higher alpha-toxin production than strains from healthy con-
trols, while the amount of alpha-toxin produced was correlated with disease severity [51].
The other toxins detected in biofilms in this study, including HlgB and the leukocidins D/ E,
have also been associated with S. aureus skin colonization and infection. This is supported by
data from both murine models [52,53] and clinical-epidemiological studies [54,55]. Other data
also supports the presence of other, non-toxin proteins detected in this study. For instance, the
detected lipase might support the persistence of S. aureus in the fatty secretions of mammalian
skin [56,57]. A recent study demonstrated that lipases are essential for S. aureus biofilm forma-
tion [56].
The PHG used in this study to establish bacterial protein presence consisted of a previously
described pool of serum from both nasal and non-nasal carriers of S. aureus [35]. Specific IgG
against all tested proteins was detected in PHG and these IgG levels were generally higher than
in serum from individual patients suffering from a S. aureus bacteremia [27] (unpublished
data). Combined with the high sensitivity of the Luminex assay [58,59] we think that it is
unlikely that the current CLA would not detect antibody absorption by IgG-accessible proteins.
However, future studies using other antibody sources (e.g. specific monoclonal antibodies)
might further increase the sensitivity of this assay.
A limitation of the PHG used in this study is the aspecific decrease in IgG that was observed
against leukocidins S and F, while genes for these proteins were not present in strain
LUH14616 and proteomics data could not confirm the presence of HlgB or Luk D/E in 8-hrs
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biofilms on PS. The known immunological cross-reactivity between Luk D/E, S/F and HlgB
[60,61] may explain these conflicting findings. In addition, an incomplete protein library used
during mass-spec analysis might explain why CLA results for a particular protein could not be
confirmed. Additional mass-spectrometry should be performed on mature biofilms on LEMs
to confirm or exclude the presence of these proteins.
Expression on LEMs of hla, the gene encoding alpha toxin, was confirmed for two strains
using GFP reporter technology. The low levels of hla expression by the USA300-derived strain
Sac042w may be explained by strain-specific traits [62], possibly caused by mutations in
upstream regulators such as sarA [63]. Interestingly, for strain LUH14616 hla expression was
also observed on PS, while CLA nor mass-spectrometry detected alpha toxin at the protein
level on this surface. This suggests that hla is transcribed but not translated and/or that the pro-
tein is rapidly degraded by the bacteria on PS, which has been observed previously for other S.
aureus strains during planktonic growth [63–66].
Regulation of hla and other genes for S. aureus virulence factors is influenced by many fac-
tors, including the accessory gene regulatory locus (Agr), RNAIII [67], downstream transcrip-
tion factors Rot [68,69], SarA and -S and Sae [70]. In this connection, we noted that several
proteins detected during biofilm formation on LEMs, including alpha-toxin, LytM, SSLs and
Spa are (indirectly) regulated by RNAIII [67,71]. Moreover, RNAIII can also directly interfere
with mRNA of LytM leading to its down-regulation [72]. Therefore, it may well be that the
quorum sensing system of AgrA/RNAIII of S. aureus is activated differently upon interaction
of S. aureus with either LEMs or PS, leading to up- or down-regulation of specific genes
depending on the surface. However, further studies including quantitative mass-spectrometry
and transcriptomic analysis are necessary to clarify the role of the diverse regulatory systems
[73–75] involved in the expression of hla and other genes during biofilm formation on LEMs.
In the context of new anti-infective therapies, such as vaccines, our data indicate that diverse
proteins of S. aureus in biofilms are accessible to human IgG. Although biofilm-associated bac-
teria are thought to be more resistant to antimicrobials and effectors of the human immune
system [13–15], our data suggests that, in addition to animal models [41], also vaccine-boosted
human antibodies can target biofilms. Further insights into the functionality of antibodies, spe-
cifically in regard to (the inhibition of) biofilm growth, are required.
Alternatively, it may be interesting to choose an anti-virulence based therapy, for example
by targeting interfering RNAs, such as RNAIII that affect the expression of many virulence fac-
tors [76]. For example, the RnpA- inhibitor RNPA1000, was shown to have in vitro antimicro-
bial effect against S. aureus (and other gram positive pathogens). Moreover, this enzyme dose-
dependently protected against the pathogenesis of S. aureus in a mouse infection model [77].
Based on our data such an anti-virulence therapy may be effective against biofilms on skin of
e.g. AD patients colonized by S. aureus, but not against biofilms on abiotic surfaces, such as
that of a colonized catheter.
We conclude that functionally diverse virulence factors of (methicillin-resistant) S. aureus
are present during biofilm formation on PS and LEMs. We specifically confirmed the presence
of alpha-toxin during biofilm formation of MRSA strains LUH14616 and Sac042w on LEMs.
In addition, the presence of several toxins, including alpha-toxin, immune modulators and
other proteins appear to differ depending on the studied strain and surface. These observations
merit more mechanistic studies to elucidate the function of specific proteins and the regulation
of their expression within S. aureus biofilms. However, the present data further suggests that
specific proteins, such as the ubiquitously present IsdA or SA0688, could be potential targets
for novel agents to prevent biofilm formation and/or to reduce biofilm formation not only in
animal models but also on human biotic surfaces.
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Supporting Information
S1 Fig. Detection of S. aureus toxins and immune-modulators in 24 hrs biofilms of
LUH14616 and surrounding medium. Results are shown for (A) alpha-toxin, (B) HlgB, (C)
FlipR, and (D) SSL1. Remaining non-bound IgG specific against the different proteins was sep-
arately measured after incubation of PHG with biofilms on PS and after incubation with the
IMDM culture medium covering the biofilms. Closed squares indicate IgG measurements
from the biofilm samples and open triangles indicate measurements from medium samples.
Biofilm mass on PS is indicated by open squares, which are plotted on the right Y-axis. Dashed
horizontal lines indicate average MFI of sterile controls. Results are presented as the mean of
2–4 experiments.
(TIF)
S2 Fig. Expression of hla by S. aureus LUH14616 and Sac042w during biofilm formation
on PS. LUH14616 and Sac042w containing hla-GFP (hla), an empty vector or a construct
yielding constant GFP expression (GFP), at 4 hrs and 24 hrs after bacterial colonization of PS.
hla expressing bacteria are presented in green.
(TIF)
S1 File. Bacterial proteins used for the competitive Luminex assay.
(DOCX)
S1 Table. Detection of mRNA and proteins in biofilms of three S. aureus strains on LEMs
and PS.
(DOCX)
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